Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents
Status:
Active, not recruiting
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
The EuroNet-PHL-C2 trial is an international, multicentre, randomised controlled trial with
the aims to reduce the indication for radiotherapy in newly diagnosed patients with classical
Hodgkin lymphoma without compromising cure rates and to investigate a chemotherapy
intensification randomisation in intermediate and advanced classical Hodgkin lymphoma to
compensate for reduction in radiotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Prof. Dr. Christine Mauz-Körholz University of Giessen
Collaborators:
Deutsche Krebshilfe e.V., Bonn (Germany) Euronet Worldwide